Selected research
Industry Growth & Trends
Global Methotrexate Sodium Industry Growth and Trends Forecast to 2032
Market perspective
The global Methotrexate Sodium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Methotrexate Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Methotrexate Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Methotrexate Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Methotrexate Sodium include HOSPIRA, Qualitest(DAVA Pharmaceuticals), Roxane Laboratories Inc., STADA Pharmaceuticals, Inc, Teva USA(Barr Laboratories) and Mylan Pharmaceuticals Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Methotrexate Sodium market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Methotrexate Sodium market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Methotrexate Sodium market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Methotrexate Sodium.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Methotrexate Sodium market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Methotrexate Sodium Market by Company
HOSPIRA
Qualitest(DAVA Pharmaceuticals)
Roxane Laboratories Inc.
STADA Pharmaceuticals, Inc
Teva USA(Barr Laboratories)
Mylan Pharmaceuticals Inc.
Methotrexate Sodium Segment by Type
Methotrexate Sodium Tablet
Methotrexate Sodium Solution
Methotrexate Sodium Segment by Application
Oral
Injection
Methotrexate Sodium Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Methotrexate Sodium manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Methotrexate Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Methotrexate Sodium Tablet
- Methotrexate Sodium Solution
Applications
- Oral
- Injection
Companies covered
- HOSPIRA
- Qualitest(DAVA Pharmaceuticals)
- Roxane Laboratories Inc.
- STADA Pharmaceuticals, Inc
- Teva USA(Barr Laboratories)
- Mylan Pharmaceuticals Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Methotrexate Sodium Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Methotrexate Sodium Sales Estimates and Forecasts (2021-2032)
- 1.3 Methotrexate Sodium Market by Type
- 1.3.1 Methotrexate Sodium Tablet
- 1.3.2 Methotrexate Sodium Solution
- 1.4 Global Methotrexate Sodium Market Size by Type
- 1.4.1 Global Methotrexate Sodium Market Size Overview by Type (2021-2032)
- 1.4.2 Global Methotrexate Sodium Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Methotrexate Sodium Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Methotrexate Sodium Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Methotrexate Sodium Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Methotrexate Sodium Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Methotrexate Sodium Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Methotrexate Sodium Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Methotrexate Sodium Industry Trends
- 2.2 Methotrexate Sodium Industry Drivers
- 2.3 Methotrexate Sodium Industry Opportunities and Challenges
- 2.4 Methotrexate Sodium Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Methotrexate Sodium Revenue (2021-2026)
- 3.2 Global Top Players by Methotrexate Sodium Sales (2021-2026)
- 3.3 Global Top Players by Methotrexate Sodium Price (2021-2026)
- 3.4 Global Methotrexate Sodium Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Methotrexate Sodium Major Company Production Sites & Headquarters
- 3.6 Global Methotrexate Sodium Company, Product Type & Application
- 3.7 Global Methotrexate Sodium Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Methotrexate Sodium Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Methotrexate Sodium Players Market Share by Revenue in 2025
- 3.8.3 2025 Methotrexate Sodium Tier 1, Tier 2, and Tier 3
4 Methotrexate Sodium Regional Status and Outlook
- 4.1 Global Methotrexate Sodium Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Methotrexate Sodium Historic Market Size by Region
- 4.2.1 Global Methotrexate Sodium Sales in Volume by Region (2021-2026)
- 4.2.2 Global Methotrexate Sodium Sales in Value by Region (2021-2026)
- 4.2.3 Global Methotrexate Sodium Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Methotrexate Sodium Forecasted Market Size by Region
- 4.3.1 Global Methotrexate Sodium Sales in Volume by Region (2027-2032)
- 4.3.2 Global Methotrexate Sodium Sales in Value by Region (2027-2032)
- 4.3.3 Global Methotrexate Sodium Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Methotrexate Sodium by Application
- 5.1 Methotrexate Sodium Market by Application
- 5.1.1 Oral
- 5.1.2 Injection
- 5.2 Global Methotrexate Sodium Market Size by Application
- 5.2.1 Global Methotrexate Sodium Market Size Overview by Application (2021-2032)
- 5.2.2 Global Methotrexate Sodium Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Methotrexate Sodium Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Methotrexate Sodium Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Methotrexate Sodium Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Methotrexate Sodium Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Methotrexate Sodium Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Methotrexate Sodium Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 HOSPIRA
- 6.1.1 HOSPIRA Company Information
- 6.1.2 HOSPIRA Business Overview
- 6.1.3 HOSPIRA Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 HOSPIRA Methotrexate Sodium Product Portfolio
- 6.1.5 HOSPIRA Recent Developments
- 6.2 Qualitest(DAVA Pharmaceuticals)
- 6.2.1 Qualitest(DAVA Pharmaceuticals) Company Information
- 6.2.2 Qualitest(DAVA Pharmaceuticals) Business Overview
- 6.2.3 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Product Portfolio
- 6.2.5 Qualitest(DAVA Pharmaceuticals) Recent Developments
- 6.3 Roxane Laboratories Inc.
- 6.3.1 Roxane Laboratories Inc. Company Information
- 6.3.2 Roxane Laboratories Inc. Business Overview
- 6.3.3 Roxane Laboratories Inc. Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Roxane Laboratories Inc. Methotrexate Sodium Product Portfolio
- 6.3.5 Roxane Laboratories Inc. Recent Developments
- 6.4 STADA Pharmaceuticals, Inc
- 6.4.1 STADA Pharmaceuticals, Inc Company Information
- 6.4.2 STADA Pharmaceuticals, Inc Business Overview
- 6.4.3 STADA Pharmaceuticals, Inc Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 STADA Pharmaceuticals, Inc Methotrexate Sodium Product Portfolio
- 6.4.5 STADA Pharmaceuticals, Inc Recent Developments
- 6.5 Teva USA(Barr Laboratories)
- 6.5.1 Teva USA(Barr Laboratories) Company Information
- 6.5.2 Teva USA(Barr Laboratories) Business Overview
- 6.5.3 Teva USA(Barr Laboratories) Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Teva USA(Barr Laboratories) Methotrexate Sodium Product Portfolio
- 6.5.5 Teva USA(Barr Laboratories) Recent Developments
- 6.6 Mylan Pharmaceuticals Inc.
- 6.6.1 Mylan Pharmaceuticals Inc. Company Information
- 6.6.2 Mylan Pharmaceuticals Inc. Business Overview
- 6.6.3 Mylan Pharmaceuticals Inc. Methotrexate Sodium Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Mylan Pharmaceuticals Inc. Methotrexate Sodium Product Portfolio
- 6.6.5 Mylan Pharmaceuticals Inc. Recent Developments
7 North America by Country
- 7.1 North America Methotrexate Sodium Sales by Country
- 7.1.1 North America Methotrexate Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Methotrexate Sodium Sales by Country (2021-2026)
- 7.1.3 North America Methotrexate Sodium Sales Forecast by Country (2027-2032)
- 7.2 North America Methotrexate Sodium Market Size by Country
- 7.2.1 North America Methotrexate Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Methotrexate Sodium Market Size by Country (2021-2026)
- 7.2.3 North America Methotrexate Sodium Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Methotrexate Sodium Sales by Country
- 8.1.1 Europe Methotrexate Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Methotrexate Sodium Sales by Country (2021-2026)
- 8.1.3 Europe Methotrexate Sodium Sales Forecast by Country (2027-2032)
- 8.2 Europe Methotrexate Sodium Market Size by Country
- 8.2.1 Europe Methotrexate Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Methotrexate Sodium Market Size by Country (2021-2026)
- 8.2.3 Europe Methotrexate Sodium Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Methotrexate Sodium Sales by Country
- 9.1.1 Asia-Pacific Methotrexate Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Methotrexate Sodium Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Methotrexate Sodium Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Methotrexate Sodium Market Size by Country
- 9.2.1 Asia-Pacific Methotrexate Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Methotrexate Sodium Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Methotrexate Sodium Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Methotrexate Sodium Sales by Country
- 10.1.1 South America Methotrexate Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Methotrexate Sodium Sales by Country (2021-2026)
- 10.1.3 South America Methotrexate Sodium Sales Forecast by Country (2027-2032)
- 10.2 South America Methotrexate Sodium Market Size by Country
- 10.2.1 South America Methotrexate Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Methotrexate Sodium Market Size by Country (2021-2026)
- 10.2.3 South America Methotrexate Sodium Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Methotrexate Sodium Sales by Country
- 11.1.1 Middle East and Africa Methotrexate Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Methotrexate Sodium Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Methotrexate Sodium Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Methotrexate Sodium Market Size by Country
- 11.2.1 Middle East and Africa Methotrexate Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Methotrexate Sodium Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Methotrexate Sodium Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Methotrexate Sodium Value Chain Analysis
- 12.1.1 Methotrexate Sodium Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Methotrexate Sodium Production Mode & Process
- 12.2 Methotrexate Sodium Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Methotrexate Sodium Distributors
- 12.2.3 Methotrexate Sodium Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst